Equities

Lepu Scientech Medical Technology Shanghai Co Ltd

Lepu Scientech Medical Technology Shanghai Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)16.68
  • Today's Change-0.600 / -3.47%
  • Shares traded126.00k
  • 1 Year change-41.06%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Lepu Scientech Medical Technology Shanghai Co Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of interventional medical devices for structural heart disease. The Company operates primarily through two segments. The Occluder Business segment is mainly engaged in the research and development and sales of a series of interventional treatment series occluders for defective congenital heart disease. The Heart Valve Business segment is mainly engaged in the research and development of heart valve medical devices. The Company operates primarily in the domestic market.

  • Revenue in HKD (TTM)439.41m
  • Net income in HKD231.67m
  • Incorporated2021
  • Employees239.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Modern Dental Group Ltd3.27bn408.15m3.36bn7.18k8.271.246.141.030.4290.4293.442.850.84719.385.14465,149.5010.527.0512.358.3453.4050.7712.419.242.5810.750.240539.9812.086.5083.3036.462.42--
OrbusNeich Medical Group Holdings Ltd1.18bn301.36m3.45bn1.28k11.501.1910.182.930.36270.36271.423.500.38391.154.20943,274.209.83--10.63--68.71--25.61--8.32--0.0214--12.45--143.76------
China Isotope & Radiation Corp7.20bn428.14m3.51bn3.13k8.200.68913.160.48771.341.3422.5215.930.5253.371.802,319,527.006.266.5712.8513.2651.6359.8911.9212.621.6757.070.218728.277.8215.35-5.432.883.632.89
Zylox-Tonbridge Medical Technolgy Co Ltd712.85m27.55m3.60bn756.00130.751.0755.625.060.08410.08412.1810.290.19571.16473.84931,828.600.7561--0.8234--71.62--3.86--3.38--0.0255--57.97--30.66------
Shanghai INT Medical Instruments Co Ltd865.15m189.59m4.95bn1.73k24.972.7419.135.721.131.135.1110.250.41282.0812.01552,105.408.818.6310.419.7660.1659.4421.3426.162.06--0.038431.8028.5029.9618.7921.7645.75--
MicroPort NeuroScientic Corp832.13m241.71m5.41bn534.0022.502.9718.496.500.41550.41551.433.150.38991.178.301,457,322.0010.91--12.61--74.12--27.97--4.53--0.0282--21.61--768.73------
AK Medical Holdings Ltd1.18bn202.79m5.64bn974.0027.682.1118.944.760.18140.18141.062.380.35140.75731.971,125,532.006.029.277.4611.2860.9165.0617.1321.782.58--0.04822.653.9712.74-11.074.6721.675.88
Yidu Tech Inc866.96m-209.41m5.76bn902.00--1.34--6.64-0.1991-0.19910.82444.070.1658114.901.36961,148.50-4.54-35.96-5.35-51.3842.0634.80-27.41-159.716.77--0.0227--0.295351.2368.96---2.99--
Lepu Scientch Mdcl Tchnlgy Shnghi Co Ltd439.41m231.67m5.99bn239.0025.862.9724.5913.640.66810.66811.275.830.20250.64037.162,006,447.0010.68--11.59--89.26--52.72--5.34--0.0014--31.58--864.81------
Shanghai Conant Optical Co Ltd2.05bn405.16m6.07bn2.76k14.843.8812.952.970.95940.95944.843.670.93532.325.94815,548.5018.5212.5725.2718.6938.3735.2719.8014.641.70--0.130418.5712.7015.5631.5633.0413.49--
New Horizon Health Ltd1.46bn118.83m6.47bn1.04k59.472.0241.834.420.23780.23783.207.010.45362.162.081,666,325.003.67--3.99--88.74--8.10--10.50--0.1305--259.54--97.40------
LifeTech Scientific Corp1.38bn267.08m6.85bn1.41k24.611.8641.934.980.06010.06010.31110.7940.28770.6179.19951,249.001.817.092.168.5178.5879.666.3022.692.02--0.16350.0015.4817.88-19.0916.8026.11--
Kangji Medical Holdings Ltd1.05bn574.06m7.09bn964.0011.952.8012.466.730.49030.49030.89992.090.2291.835.071,050,468.0011.6414.4016.9016.1879.7881.7550.8457.241.74--0.0031111.8117.7621.235.2828.0041.50--
Shanghai MicroPort MedBot Group Co Ltd167.82m-805.99m8.89bn560.00--29.70--52.97-0.8408-0.84080.17510.30810.1090.45310.52258,180.00-52.93---82.38--25.37---485.67--0.637-6.990.6773--384.16--11.20------
Data as of Nov 22 2024. Currency figures normalised to Lepu Scientech Medical Technology Shanghai Co Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

0.30%Per cent of shares held by top holders
HolderShares% Held
China Asset Management Co., Ltd.as of 30 Jun 2024367.00k0.11%
Bosera Asset Management Co., Ltd.as of 30 Jun 2024281.00k0.08%
Penghua Fund Management Co., Ltd.as of 30 Jun 2024101.00k0.03%
China Asset Management (Hong Kong) Ltd.as of 30 Sep 202481.54k0.02%
Mellon Investments Corp.as of 07 Nov 202478.00k0.02%
SSgA Funds Management, Inc.as of 07 Nov 202445.00k0.01%
China Southern Asset Management Co., Ltd.as of 30 Jun 202441.00k0.01%
China Universal Asset Management Co., Ltd.as of 30 Jun 202423.00k0.01%
Franklin Templeton Sealand Fund Management Co., Ltd.as of 30 Jun 202419.00k0.01%
Ping An Fund Management Co., Ltd.as of 30 Jun 202419.00k0.01%
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.